Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lyn is a non-receptor tyrosine-protein kinase belonging to the Src family kinases (SFKs). It is primarily expressed in hematopoietic cells and plays a crucial role in both activating and inhibiting signaling pathways within immune cells, particularly B cells. Lyn is involved in B-cell differentiation, proliferation, survival, apoptosis, and self-tolerance. Dysregulation of Lyn can lead to autoimmune diseases or myeloid neoplasia. It transmits signals from various cell surface receptors and modulates downstream cascades like PI3K-AKT and MAPK.
Phosphorylation of ITAMs and ITIMs, modulation of downstream signaling pathways (PI3K-AKT, MAPK, STAT)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lyn protein tyrosine kinase.